This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
CV Ingenuity (A): How to Evaluate the Commercial Viability of New Health Care Technologies
Herzlinger, Regina E.; Otazo, AndrewCase HBS-315045-EEntrepreneurshipA medical device startup seeks to complete its clinical trials with very little startup funding and a small staff when compared to its competitors.Starting at €8.20
-
Caso de estudio: Un inversionista ngel con una agenda personal
Herzlinger, Regina E.; Munoz-Seca, BeatrizArticle HBS-R1103MEntrepreneurshipGloria Londoño, el dueño de una cadena de centros de día innovadoras e integrales para las personas mayores en España, se ofrece 3 millones de euros por Victor Serna, un acaudalado médico-inversor. A cambio, Serna quiere una participación del 25%, un puesto en la junta, un voto en todas las decisiones estratégicas, y la posibilidad de liquidar su posición en cinco años, ya sea a través de una oferta pública o una venta. Sus términos no son negoci...Starting at €8.20
-
An Angel Investor with an Agenda (HBR Case Study)
Herzlinger, Regina E.; Munoz-Seca, BeatrizArticle HBS-R1103X-EEntrepreneurshipGloria Londono, the owner of a chain of innovative, holistic day care centers for the elderly in Spain, is offered 3 million euro by Victor Serna, a wealthy physician-investor. In exchange, Serna wants a 25% stake, a board seat, a vote on all strategic decisions, and the ability to liquidate his position in five years, either through a public offering or a sale. His terms are not negotiable; his objectives are not transparent. The money would ena...Starting at €8.20
-
The Global Sight Initiative
Herzlinger, Regina E.Case HBS-311034-EEntrepreneurshipHow to replicate a 'one of' social entrepreneurship effort: To cure blindness, Seva took the Aravind Eye Hospital & scaled it up to 100 hospitals globally.Starting at €8.20
-
Avid Radiopharmaceuticals: The Venture Debt Question
Rhodes-Kropf, Matthew; Leamon, AnnCase HBS-809086-EEntrepreneurshipThe CEO of a promising biotech company must decide how to respond to the macro-economic slump of late 2008. He had planned to pursue an aggressive schedule moving the firm's Alzheimer's and Parkinson's disease imaging compounds through clinical trials and into the market. This involved expanding the firm's facilities and headcount and he planned to fund this by taking venture debt. Although clinical trial data is extremely encouraging, questions ...Starting at €8.20
-
The Impact of Waves in Venture Capital and Private Equity, Module Note for Instructors
Rhodes-Kropf, MatthewTeaching Note HBS-814084-EEntrepreneurshipStarting at €0.00
-
VCPE Strategy Vignettes I, II, and 2012, Teaching Note
Rhodes-Kropf, Matthew; Burbank, NathanielTeaching Note HBS-814086-EEntrepreneurshipTeaching Note for 811043, 811054, and 812073.Starting at €0.00
-
Iris Running Crane: December 2009
Rhodes-Kropf, Matthew; Lerner, Josh; Leamon, AnnCase HBS-810073-EEntrepreneurshipIris Running Crane, an MBA candidate, must choose among three different job offers in private equity. One is with a top-tier megafund buyout operation; the second with a geographically focused mid-market fund; and the third with a one-time top-tier fund that is trying to reposition itself as a turnaround expert, starting with its own portfolio. Iris must consider the advantages and drawbacks of each position, and how each will help her achieve he...Starting at €8.20
-
Investcorp and the Moneybookers Bid
Rhodes-Kropf, Matthew; Knoop, Carin-Isabel; Lietz, Nori GerardoCase HBS-811013-EEntrepreneurshipIn January 2007, Hazem Ben-Gacem, managing director and co-head of Investcorp Technology Partners (ITP), needs to decide what to bid at an auction for Moneybookers Limited, one of the top three e-payment solution providers in Europe. However, approximately 70% of Moneybookers revenues were related to transactions from online gaming sites (down from 100% in 2002). Although the thesis was that e-commerce transactions would soon make up a much large...Starting at €8.20
-
Avid Radiopharmaceuticals and Lighthouse Capital Partners, Teaching Note
Rhodes-Kropf, Matthew; Leamon, AnnTeaching Note HBS-812066-EEntrepreneurshipTeaching Note for 810054.Starting at €0.00